Literature DB >> 10733979

DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

J Malina1, C Hofr, L Maresca, G Natile, V Brabec.   

Abstract

Modifications of natural DNA and synthetic oligodeoxyribonucleotide duplexes in a cell-free medium by analogs of antitumor cisplatin containing enantiomeric amine ligands, such as cis-[PtCl(2)(RR-DAB)] and cis-[PtCl(2)(SS-DAB)] (DAB = 2,3-diaminobutane), were studied by various methods of molecular biophysics and biophysical chemistry. These methods include DNA binding studies by pulse polarography and atomic absorption spectrophotometry, mapping of DNA adducts using transcription assay, interstrand cross-linking assay using gel electrophoresis under denaturing conditions, differential scanning calorimetry, chemical probing, and bending and unwinding studies of the duplexes containing single, site-specific cross-link. The major differences resulting from the modification of DNA by the two enantiomers are the thermodynamical destabilization and conformational distortions induced in DNA by the 1,2-d(GpG) intrastrand cross-link. It has been suggested that these differences are associated with a different biological activity of the two enantiomers observed previously. In addition, the results of the present work are also consistent with the view that formation of hydrogen bonds between the carbonyl oxygen of the guanine residues and the "quasi equatorial" hydrogen of the cis amine in the 1, 2-d(GpG) intrastrand cross-link plays an important role in determining the character of the distortion induced in DNA by this lesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733979      PMCID: PMC1300793          DOI: 10.1016/S0006-3495(00)76748-8

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  51 in total

1.  Synthesis, mutagenicity, binding to pBR 322 DNA and antitumour activity of platinum(II) complexes with ethambutol.

Authors:  M Coluccia; F P Fanizzi; G Giannini; D Giordano; F P Intini; G Lacidogna; F Loseto; M A Mariggio; A Nassi; G Natile
Journal:  Anticancer Res       Date:  1991 Jan-Feb       Impact factor: 2.480

2.  Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  Y Corda; C Job; M F Anin; M Leng; D Job
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

3.  Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides.

Authors:  V Brabec; E Palecek
Journal:  Biophys Chem       Date:  1976-01       Impact factor: 2.352

4.  The influence of salts and pH on polarographic currents produced by denatured DNA.

Authors:  V Brabec; E Palecek
Journal:  Biophysik       Date:  1970

5.  Helical repeat of DNA in solution.

Authors:  J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Helical periodicity of DNA determined by enzyme digestion.

Authors:  D Rhodes; A Klug
Journal:  Nature       Date:  1980-08-07       Impact factor: 49.962

8.  Detection of an unusual distortion in A-tract DNA using KMnO4: effect of temperature and distamycin on the altered conformation.

Authors:  J G McCarthy; A Rich
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

9.  Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.

Authors:  Y Kidani; K Inagaki; M Iigo; A Hoshi; K Kuretani
Journal:  J Med Chem       Date:  1978-12       Impact factor: 7.446

10.  DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.

Authors:  V Brabec; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  11 in total

1.  Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.

Authors:  C Hofr; N Farrell; V Brabec
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

2.  Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).

Authors:  Sophie Bombard; Marzia Bruna Gariboldi; Elena Monti; Elisabetta Gabano; Luca Gaviglio; Mauro Ravera; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-03-24       Impact factor: 3.358

3.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

Authors:  Hana Kostrhunova; Jaroslav Malina; Amanda J Pickard; Jana Stepankova; Marie Vojtiskova; Jana Kasparkova; Tereza Muchova; Matthew L Rohlfing; Ulrich Bierbach; Viktor Brabec
Journal:  Mol Pharm       Date:  2011-08-17       Impact factor: 4.939

5.  Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear Pt(II) complexes.

Authors:  Jakub Florian; Jana Kasparkova; Nicholas P Farrell; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

6.  Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.

Authors:  Olivier Delalande; Jaroslav Malina; Viktor Brabec; Jirí Kozelka
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

7.  Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.

Authors:  Jana Kasparkova; Victoria Marini; Vendula Bursova; Viktor Brabec
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

8.  DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.

Authors:  Olga Novakova; Jana Kasparkova; Jaroslav Malina; Giovanni Natile; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

9.  Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA.

Authors:  Jaroslav Malina; Jana Kasparkova; Nicholas P Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2010-09-09       Impact factor: 16.971

Review 10.  Chiral discrimination in platinum anticancer drugs.

Authors:  Michele Benedetti; Jaroslav Malina; Jana Kasparkova; Viktor Brabec; Giovanni Natile
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.